Cooper Companies buys into women's health testing
This article was originally published in Clinica
Executive Summary
The Cooper Companies is paying $10 million to buy a 10% share in Litmus Concepts in order to gain exclusive US and Canadian marketing rights to four doctor's office diagnostic tests aimed at the women's healthcare market. Cooper expects that, as the tests are launched through its CooperSurgical division, the products will add between $30 million and $50 million to the company's revenue.